Kiniksa Pharmaceuticals
KNSA
KNSA
154 hedge funds and large institutions have $768M invested in Kiniksa Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 51 increasing their positions, 49 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 49
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3.77% less ownership
Funds ownership: 101.18% → 97.41% (-3.8%)
Holders
154
Holding in Top 10
3
Calls
$4.38M
Puts
$3.09M
Top Buyers
| 1 | +$61.9M | |
| 2 | +$27.5M | |
| 3 | +$20M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$8.29M |
| 5 |
State Street
Boston,
Massachusetts
|
+$6.76M |
Top Sellers
| 1 | -$37.9M | |
| 2 | -$14M | |
| 3 | -$5.99M | |
| 4 |
Walleye Capital
New York
|
-$5.74M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$3.99M |